Neurocrine Biosciences, Inc.
US ˙ NasdaqGS ˙ US64125C1099

SecurityNBIX / Neurocrine Biosciences, Inc.
InstitutionFifth Third Bancorp
Latest Disclosed Ownership27,393 shares
Latest Disclosed Value $ 3,608,704
Fifth Third Bancorp reports 3,070.49% increase in ownership of NBIX / Neurocrine Biosciences, Inc.

On May 1, 2026 - Fifth Third Bancorp filed a 13F-HR form disclosing ownership of 27,393 shares of Neurocrine Biosciences, Inc. (US:NBIX) valued at $3,608,754 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 864 shares of Neurocrine Biosciences, Inc.. This represents a change in shares of 3,070.49% during the quarter. The current value of the position is $4,522,858 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 27,393 26,529 3,070.49 3,609 2,857.38 0.0066
2026-02-02 2025-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 864 16 1.89 123 2.52 0.0004
2025-11-07 2025-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 848 29 3.54 119 16.67 0.0004
2025-07-15 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 819 -237 -22.44 103 -12.07 0.0004
2025-04-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,056 254 31.67 117 6.42 0.0004
2025-01-21 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 802 -2 -0.25 109 18.48 0.0004
2024-10-17 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 804 88 12.29 93 -6.12 0.0003
2024-07-22 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 716 92 14.74 99 13.95 0.0004
2024-04-23 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 624 32 5.41 86 10.26 0.0003
2024-01-19 2023-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 592 -30 -4.82 78 13.04 0.0003
2023-10-31 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 622 211 51.34 70 81.58 0.0003
2023-07-26 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 411 62 17.77 39 8.57 0.0002
2023-04-24 2023-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 349 48 15.95 35 0.00 0.0002
2023-01-25 2022-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 301 -15 -4.75 36 2.94 0.0002
2022-10-25 2022-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 316 -103 -24.58 34 -17.07 0.0002
2022-08-04 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 419 102 32.18 41 36.67 0.0002
2022-04-19 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 317 69 27.82 30 42.86 0.0001
2022-02-01 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 248 0 0.00 21 -12.50 0.0001
2021-10-15 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 248 238 2,380.00 24 2,300.00 0.0001
2021-08-06 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 10 10 1 0.0000
2020-08-05 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -104 -100.00 0 -100.00
2020-05-05 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 104 -18 -14.75 9 -30.77 0.0001
2020-02-14 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 122 18 17.31 13 44.44 0.0001
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 104 -896 -89.60 9 -89.29 0.0001
2019-08-07 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,000 0 0.00 84 -4.55 0.0005
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,000 999 99,900.00 88 4.76 0.0006
2019-02-14 2018-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 1 -88 -98.88 0 -100.00
2018-11-14 2018-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 89 -77 -46.39 11 -31.25 0.0001
2018-08-14 2018-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 166 0 0.00 16 14.29 0.0001
2018-05-15 2018-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 166 -176 -51.46 14 -48.15 0.0001
2018-02-14 2017-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 342 -392 -53.41 27 -40.00 0.0002
2017-11-14 2017-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 734 -225 -23.46 45 2.27 0.0003
2017-08-11 2017-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 959 52 5.73 44 12.82 0.0003
2017-05-12 2017-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 907 408 81.76 39 56.00 0.0003
2017-02-09 2016-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 499 0 0.00 25 0.00 0.0002
2016-11-10 2016-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 499 -3,507 -87.54 25 -86.26 0.0002
2016-08-11 2016-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 4,006 -1,031 -20.47 182 -8.54 0.0015
2016-05-13 2016-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,037 -31 -0.61 199 -30.66 0.0017
2016-02-16 2015-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 5,068 3,864 320.93 287 497.92 0.0025
2015-11-13 2015-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 1,204 -1,357 -52.99 48 -60.66 0.0004
2015-08-14 2015-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,561 -85 -3.21 122 16.19 0.0011
2015-05-14 2015-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,646 2,646 105 0.0009
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.